Which feature best distinguishes acute post-streptococcal glomerulonephritis (PSGN) from acute rheumatic fever (ARF), both occurring after Streptococcus pyogenes infection?

## Distinguishing PSGN from ARF ### Clinical Context Both conditions follow Group A Streptococcal (GAS) infection, but they represent distinct immunopathological sequelae with different organ tropism and pathogenesis. ### Key Differentiating Feature **Key Point:** Haematuria and proteinuria with **low complement C3 levels** is the best distinguishing feature of PSGN from ARF. In PSGN, immune complex deposition in the glomeruli activates the alternative complement pathway, consuming C3 (while C4 remains relatively normal). ARF does **not** cause renal involvement or complement consumption. ### Why Option C (Cardiac involvement / Aschoff bodies) Is Incorrect as the Best Distinguishing Feature While cardiac involvement with Aschoff bodies is indeed pathognomonic for ARF, the question asks what **best distinguishes PSGN from ARF** — i.e., a feature unique to PSGN that is absent in ARF. Option A (haematuria, proteinuria, low C3) is a positive finding in PSGN that is absent in ARF, making it the superior distinguishing feature from PSGN's perspective. Option C describes ARF's hallmark, not PSGN's. ### Comparison Table | Feature | PSGN | ARF | |---|---|---| | **Primary organ** | Kidney (glomeruli) | Heart (myocardium, valves) | | **Pathology** | IgG/IgA immune complex deposition | Aschoff bodies (granulomatous inflammation) | | **C3 complement** | **Low** (alternative pathway activation) | Normal | | **Urinalysis** | **Haematuria, proteinuria, RBC casts** | Normal | | **Cardiac findings** | None | Aortic/mitral regurgitation, pericarditis | | **Latency** | 1–3 weeks (skin/throat) | 2–3 weeks (throat only) | | **ASO titre** | Elevated | Elevated | ### Why Other Options Are Incorrect - **Option B:** Latency periods overlap significantly (1–3 vs 2–3 weeks), making this a poor distinguishing feature. - **Option C:** Describes ARF's hallmark (Aschoff bodies), not a feature of PSGN; does not distinguish PSGN from ARF. - **Option D:** ASO titre is elevated in **both** PSGN and ARF — it is not a distinguishing feature. **Clinical Pearl:** In PSGN, serum C3 is depressed in >90% of cases during the acute phase and normalises within 6–8 weeks. Persistent hypocomplementaemia beyond 8 weeks should raise suspicion for membranoproliferative GN (MPGN). C4 is typically normal, reflecting alternative pathway activation (Harrison's Principles of Internal Medicine, 21e, Ch. 305). **High-Yield:** PSGN is self-limited and resolves in weeks; ARF can cause permanent valvular damage requiring long-term penicillin prophylaxis. Low C3 + haematuria + proteinuria = PSGN; normal complement + carditis + Aschoff bodies = ARF. [cite:Harrison 21e Ch 305; Robbins & Cotran Pathologic Basis of Disease, 10e]